Hepatotoxicity is a common clinical manifestation associated with a wide range of anticancer therapies. Because of the inherent toxicity of anticancer therapies, oncologists must maintain a broad understanding of their effects on the body, including the liver.Therefore, the study was conducted to examine the effects of two doses of L-carnitine on damaged liver as a result of giving cytarabine. Twenty-four male rat were used in the experiment. The rats divided to four group each group with six rats,the first group injected normal salineintraperitoneally and set as control group(G1),the second group injected cytarabine 25 mg/kg/bw intraperitoneally and set as (G2), the third injected cytarabine 25 mg/kg/bw and 50 mg /kg/bw L-carnitine intraperitoneally and set as (G3), the third injected cytarabine 25 mg/kg/bw and 300mg/kg/bw L-carnitine Intraperitoneally and set as(G4), the study showed that use of L-carnitine reduced the harmful effect of cytarabinein the body when compared to the group that was injected only with cytarabineat level of (p-value <0.05). ALT show a significant increase in G2 when compared to other groups the mean value was (104±7.697, 134.66±13.08, 105.66±5.89, 94.33±3.5) for groups: control, cytarabine,50mg/kg/bw & 300mg/kg/bw ofL-carnitine respectively;,,
Hepatotoxicity is a common clinical manifestation associated with a wide range of anticancer therapies. Because of the inherent toxicity of anticancer therapies, oncologists must maintain a broad understanding of their effects on the body, including the liver. Therefore, the study was conducted to examine the effects of two doses of L-carnitine on damaged liver as a result of giving cytarabine. Twenty-four male rats were used in the experiment. The rats divided to four group each group with six rats,the first group injected normal saline intraperitoneally and set as control group(G1), the second group injected cytarabine 25 mg/kg/bw, intraperitoneally and set as (G2), the third group injected cytarabine 25 mg/kg/bw and 50 mg/kg/bw, L-carnitine intraperitoneally and set as (G3), the fourth group injected cytarabine 25 mg/kg/bw and 300 mg/kg/bw, L-carnitine intraperitoneally and set as (G4), the study showed that use of L-carnitine reduced the harmful effect of cytarabine in the body when compared to other groups that were injected only with cytarabine at level of (p-value <0.05).The rats treated with L-carnitine have shown significant elevation in CAT and SOD and reduction of the level of MDA.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.